These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 1899298)

  • 21. Major histocompatibility complex class II-restricted cytotoxicity by self-myelin basic protein-reactive T-cell hybridomas: evidence for a tumour necrosis factor-independent nucleolytic mechanism.
    Rayner DC; Petrycky-Cox LD; Diocee M; Rector E
    Immunology; 1993 Feb; 78(2):273-8. PubMed ID: 7682537
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of overlapping class I and class II H-2d-restricted T cell determinants of influenza virus N1 neuraminidase that require infectious virus for presentation.
    Wysocka M; Eisenlohr LC; Otvos L; Horowitz D; Yewdell JW; Bennink JR; Hackett CJ
    Virology; 1994 May; 201(1):86-94. PubMed ID: 7513927
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of major histocompatibility molecules in antigen-specific immune responses.
    McCluskey J; Blok R; Kjer-Nielsen L
    Transplant Proc; 1989 Feb; 21(1 Pt 1):591-4. PubMed ID: 2495622
    [No Abstract]   [Full Text] [Related]  

  • 24. Effect of the expression of a hepatocyte-specific MHC molecule in transgenic mice on T cell tolerance.
    Jones-Youngblood SL; Wieties K; Forman J; Hammer RE
    J Immunol; 1990 Feb; 144(4):1187-95. PubMed ID: 2303705
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunologic considerations for therapeutic strategies utilizing allogeneic hepatocytes: hepatocyte-expressed membrane-bound major histocompatibility complex class I antigen sensitizes while soluble antigen suppresses the immune response in rats.
    Scherer MN; Graeb C; Tange S; Dyson C; Jauch KW; Geissler EK
    Hepatology; 2000 Nov; 32(5):999-1007. PubMed ID: 11050050
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synergistic effect of murine cytomegalovirus on the induction of acute graft-vs-host disease involving MHC class I differences only. Analysis of in vitro T cell function.
    Via CS; Shanley JD; Shearer GM
    J Immunol; 1990 Nov; 145(10):3283-9. PubMed ID: 2172381
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of Abeta(b-/-), H2-DM(-), and CIITA(-/-) in second-set skin allograft rejection.
    Felix NJ; de Serres S; Meyer AA; Ting JP
    J Surg Res; 2002 Feb; 102(2):185-92. PubMed ID: 11796017
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vivo priming of mouse CTL precursors directed to product of a newly defined minor H-42 locus is under a novel control of class II MHC gene.
    Ishikawa H; Suzuki H; Hino T; Kubota E; Saito K
    J Immunol; 1985 Dec; 135(6):3681-5. PubMed ID: 3934264
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Activation of T cells by superantigen in class II-negative mice.
    Avery AC; Markowitz JS; Grusby MJ; Glimcher LH; Cantor H
    J Immunol; 1994 Dec; 153(11):4853-61. PubMed ID: 7963549
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evidence for involvement of clonal anergy in MHC class I and class II disparate skin allograft tolerance after the termination of intrathymic clonal deletion.
    Tomita Y; Nishimura Y; Harada N; Eto M; Ayukawa K; Yoshikai Y; Nomoto K
    J Immunol; 1990 Dec; 145(12):4026-36. PubMed ID: 2147933
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Marked differences between orthotopic and heterotopic auxiliary liver allografts in the induction of class II MHC antigens on hepatocytes.
    Icard P; Sawyer GJ; Houssin D; Fabre JW
    Transplant Proc; 1990 Aug; 22(4):1935. PubMed ID: 2117820
    [No Abstract]   [Full Text] [Related]  

  • 32. A rat anti-mouse T4 monoclonal antibody (H129.19) inhibits the proliferation of Ia-reactive T cell clones and delineates two phenotypically distinct (T4+, Lyt-2,3-, and T4-, Lyt-2,3+) subsets among anti-Ia cytolytic T cell clones.
    Pierres A; Naquet P; Van Agthoven A; Bekkhoucha F; Denizot F; Mishal Z; Schmitt-Verhulst AM; Pierres M
    J Immunol; 1984 Jun; 132(6):2775-82. PubMed ID: 6202760
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of in vivo and in vitro immune response to purified hepatocytes.
    Bumgardner GL; Matas AJ; Chen S; Cahill D; Cunningham TR; Payne WD; Bach FH; Ascher NL
    Transplantation; 1990 Feb; 49(2):429-36. PubMed ID: 1968299
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential requirement for protein synthesis in cytolysis mediated by class I and class II MHC-restricted cytotoxic T cells.
    Tite JP
    Immunology; 1990 Aug; 70(4):440-5. PubMed ID: 2118476
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunologic consequence of class II+ pancreatic islet allografts on recipient responsiveness.
    Markmann JF; Barker CF; Lo D; Brinster R; Heber-Katz E; Naji A
    Transplant Proc; 1990 Aug; 22(4):2052-3. PubMed ID: 2143872
    [No Abstract]   [Full Text] [Related]  

  • 36. T cell-accessory cell interactions that initiate allospecific cytotoxic T lymphocyte responses: existence of both Ia-restricted and Ia-unrestricted cellular interaction pathways.
    Singer A; Kruisbeek AM; Andrysiak PM
    J Immunol; 1984 May; 132(5):2199-209. PubMed ID: 6201534
    [TBL] [Abstract][Full Text] [Related]  

  • 37. T-cell receptor transgenic analysis of tumor-specific CD8 and CD4 responses in the eradication of solid tumors.
    Marzo AL; Lake RA; Robinson BW; Scott B
    Cancer Res; 1999 Mar; 59(5):1071-9. PubMed ID: 10070965
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Functional characteristics of liver T-lymphocytes in the allogenic response to mutant MHC class I and II molecules].
    Chernysheva AD; Brondz BD; Anosova NG; Boĭko RZ; Aĭzenberg LV; Kazanskiĭ DB
    Mol Biol (Mosk); 1996; 30(3):721-8. PubMed ID: 8754021
    [No Abstract]   [Full Text] [Related]  

  • 39. Anti-class II antibodies, but not cytotoxic T-lymphocyte antigen 4-immunoglobulin hybrid molecules, prevent rejection of major histocompatibility complex class II-negative myeloma in T-cell receptor-transgenic mice.
    Dembic Z; Hofgaard PO; Omholt H; Bogen B
    Scand J Immunol; 2004; 60(1-2):143-52. PubMed ID: 15238083
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Abrogation of islet immunogenicity using an anti-MHC class I monoclonal antibody.
    Munn SR; Marjoribanks C
    Transplant Proc; 1992 Jun; 24(3):1038-9. PubMed ID: 1604509
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.